M
Miori Inoue
Researcher at Tokyo Medical and Dental University
Publications - 11
Citations - 473
Miori Inoue is an academic researcher from Tokyo Medical and Dental University. The author has contributed to research in topics: Bone marrow & Leukemia. The author has an hindex of 8, co-authored 10 publications receiving 463 citations.
Papers
More filters
Journal ArticleDOI
IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes
Yasunori Nakagawa,Shinya Abe,Morito Kurata,Maki Hasegawa,Kouhei Yamamoto,Miori Inoue,Tamiko Takemura,Kenshi Suzuki,Masanobu Kitagawa +8 more
TL;DR: Findings indicate that IAP family proteins might play a role in worsening the prognosis of MM patients in association with chemotherapy‐induced overexpression of MDR1 or LRP, and changes in the expression of IAPs induced by chemotherapy did not correlate with their prognosis.
Journal ArticleDOI
Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes.
Masakazu Sawanobori,Shuichi Yamaguchi,Maki Hasegawa,Miori Inoue,Kenshi Suzuki,Ryuichi Kamiyama,Katsuiku Hirokawa,Masanobu Kitagawa +7 more
TL;DR: TNF- alpha-induced apoptosis may play a role in ineffective hematopoiesis in "early stage MDS" bone marrow, although the regulatory mechanisms for TNF-alpha-induced signaling would be complicated and not be simply explained only by these pathways.
Journal ArticleDOI
Expression of IAP family proteins in myelodysplastic syndromes transforming to overt leukemia.
Kouhei Yamamoto,Shinya Abe,Yasunori Nakagawa,Kenshi Suzuki,Maki Hasegawa,Miori Inoue,Morito Kurata,Katsuiku Hirokawa,Masanobu Kitagawa +8 more
TL;DR: Comparing the expression of the inhibitor of apoptosis protein (IAP) gene family proteins in bone marrow samples from control, MDS, OL transformed from MDS (MDS --> OL), and de novo acute myelogenous leukemia (AML) subjects by the quantitative real-time RT-PCR method and an immunohistochemical approach indicates that these IAPs could be associated with the early events in the development of OL.
Journal ArticleDOI
Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
Yasunori Nakagawa,Shuichi Yamaguchi,Maki Hasegawa,Tetsuo Nemoto,Miori Inoue,Kenshi Suzuki,Katsuiku Hirokawa,Masanobu Kitagawa +7 more
TL;DR: Observations indicate a differential regulatory mechanism for the expression of IAP family proteins in ALL and CLL cells, although the functions of I AP families and the mechanisms of nuclear/cytoplasmic transport of survivin should be clarified in future studies.
Journal ArticleDOI
Expression of IAP-family proteins in adult acute mixed lineage leukemia (AMLL).
Yasunori Nakagawa,Maki Hasegawa,Morito Kurata,Kouhei Yamamoto,Shinya Abe,Miori Inoue,Tamiko Takemura,Katsuiku Hirokawa,Kenshi Suzuki,Masanobu Kitagawa +9 more
TL;DR: Findings suggest that higher expression of various IAPs is associated with the chemotherapy‐resistant nature of this specific type of leukemia.